American Century Companies’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-218,889
Closed -$383K 2920
2024
Q4
$383K Buy
218,889
+35,599
+19% +$66.3K ﹤0.01% 2601
2024
Q3
$354K Buy
183,290
+85,983
+88% +$168K ﹤0.01% 2586
2024
Q2
$172K Buy
97,307
+70,924
+269% +$173K ﹤0.01% 2754
2024
Q1
$71.5K Buy
+26,383
New +$63.7K ﹤0.01% 2885
2020
Q4
Sell
-27,471
Closed -$204K 2006
2020
Q3
$204K Buy
+27,471
New +$190K ﹤0.01% 1677

Other funds holding LAB

American Century Companies's LAB Position: Q1 2025 in Review

American Century Companies sold out of Standard BioTools (LAB) in Q1 2025, closing a stake of 218,889 shares — an estimated $383K sold.

American Century Companies first reported a position in LAB in Q3 2020 and held it in 5 quarters. The position peaked at $383K in Q4 2024. 145 funds tracked by Wall St. Rank hold LAB as of Q1 2025.

  • American Century Companies reported no remaining Standard BioTools position as of Q1 2025 after selling out during the quarter.
  • American Century Companies sold 218,889 Standard BioTools shares in Q1 2025, an estimated $383K.
  • American Century Companies first reported a position in Standard BioTools in Q3 2020 and held it in 5 quarters.
  • American Century Companies's Standard BioTools position peaked at $383K in Q4 2024.
  • 145 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2025.

Based on American Century Companies's 13F filing for Q1 2025, filed 13 May 2025.